Genes with increased accessibility and expression in BAP1 mutants include known ccRCC-associated genes (RAPGEF5 and SQSTM1) and EPHA signaling genes (EPHA6 and EFNA5). This evidence concerns the gene RAPGEF5 and nonpapillary renal cell carcinoma.